If you cannot read this message correctly, please click here
|
![](http://e.elijahlistmail.com/db/26630381/243447852/1.gif)
If you cannot read this message correctly, please click here
|
|
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
03/02/2020 02:00 PM EST Variability in sleep duration and timing may represent new and independent heart disease risk factor. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health.
|
![]() | |||||
cannabidiol for epilepsy | |||||
NEWS | |||||
JAMA Neurology Publishes Results from Positive Phase 3 Trial of EPIDIOLEX® (cannabidiol) oral ... EPIDIOLEX, a pharmaceutical formulation of highly purified cannabidiol ... "Dravet syndrome is one of the most difficult-to-treat forms of epilepsy and ...
| |||||
Not All Forms of CBD Work as Seizure Treatments, Study Finds Cannabidiol (CBD) -- an active compound in cannabis -- has attracted a lot of attention in recent years for its purported health benefits, but the medical ...
| |||||
Study Finds Artisanal CBD Not as Effective as Pharmaceutical CBD for Reducing Seizures Newswise — MINNEAPOLIS, MN — Children and teens with epilepsy who were treated with pharmaceutical cannabidiol (CBD) had much better ...
| |||||
2020-2025 Global and Regional Childhood Absence Epilepsy Treatment Industry Production ... The global Childhood Absence Epilepsy Treatment market report by HNY Research offers users a detailed overview of the market and all the main factors ... Ethosuximide, Valproate, Lamotrigine, CX-8998, Cannabidiol Oral Solution.
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
![]() |
Send Feedback |
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
03/02/2020 11:00 AM EST NIH-funded study reports advance in blood-based detection of ptau181, a biomarker of Alzheimer's disease. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health.
|
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
03/02/2020 11:15 AM EST Addition of hospital data informs estimates for families making treatment decisions. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health.
|
If you cannot read this message correctly, please click here
|